| Literature DB >> 22962635 |
Tom Ran1, Yehonatan Douek, Lilach Milo, Ehud Shapiro.
Abstract
An autonomous synthetic programmable device that can diagnose a cell's state according to predefined markers and produce a corresponding therapeutic output may be the basis of future programmable drugs. Motivated to increase diagnosis precision, devices that integrate multiple disease markers have been implemented based on various molecular tools. As simplicity is key to future in-vivo applications, we sought a molecular device that a) integrates multiple inputs without requiring pairwise interactions, and b) harnesses only mechanisms that cells natively use. Here we show a synthetic NOR-based programmable device, operating via a biochemical obstructing approach rather than on a constructive approach, capable of differentiating between prokaryotic cell strains based on their unique expression profile. To demonstrate our system's strengths we further implemented the NOT, OR and AND gates. The device's programmability allows context-dependent selection of the inputs being sensed, and of the expressed output, thus, holding great promise in future biomedical applications.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22962635 PMCID: PMC3435560 DOI: 10.1038/srep00641
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379